MONODICARBINOL TERMINATED POLYDIMETHYLSILOXANE, asymmetric, 50-60cSt, 100g

2-Cyclopropylthiazole-4-carbaldehyde, 97%, 250mg

6-BROMO-4-FLUOROQUINOLINE, 95.0%, 100mg

8-((1S,2S)-2-Hydroxy-2-methylcyclopentyl)-2-(methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one, 97%, 25mg

7-Fluoro-5-nitro-1h-indole, 95+%, 1g

2,6,10,14-TETRAMETHYLPENTADECANE, 95%, 100g

Microcrystalline cellulose, for thin layer chromatography, 1 kg, plastic packaging.

N-ethyl-2-phenoxyethanamine hydrochloride, 95.0%, 10g

1-CHLORO-6-ISOPROPYLISOQUINOLINE, 95%, 5g

N-(2-Fluoro-4-methylphenyl)acetamide, 97.0%, 1g

Butyric acid hydrazide, 98.0%, 100g

(2R,3R,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal, 98%, 250mg

BOC-2-PROPARGYL-L-GLYCINOL, 97.0%, 1g